Buy stocks
Invest and track all your stocks in one place.
Medicamen Biotech LtdNSE: MEDICAMEQ
NSE: MEDICAMEQ
₹494.10
-33.3
(4 Apr)
-6.3%
Loading chart
1D
1W
3M
1Y
5Y
Price
₹494.10
Today’s high
₹533.25
Today’s low
₹490.15
52W high
₹630.00
52W low
₹377.00
1Y
16.9%
PE
76.79
PB
2.91
EPS (TTM)
8.63
Dividend yield
0.2%
5Y
22.4%
Market cap
₹628.2 Cr
Volume
8,495
Average volume
2,850
Insights
MEDICAMEQ price is above its 200 day moving average
MEDICAMEQ PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.
In beta. Send feedback here.
Compare with other stock
Price
₹5,490.75
₹1,972.00
₹494.10
₹1,709.40
₹1,106.00
₹1,109.75
1D
-4.7%
-5.8%
-6.3%
-3.4%
-6.0%
-3.6%
1Y
+49.0%
+22.9%
+16.9%
+5.4%
-2.7%
-9.4%
PE
70.53
31.45
76.79
35.84
18.49
17.25
PB
10.63
5.76
2.91
5.93
2.08
2.91
EPS
77.85
62.70
6.43
47.70
59.81
64.34
Market cap
Large
Large
Mid
Large
Large
Large
Financials
Income statement
Balance sheet
Cash flow
Quarterly
Annual
As of 2023
Revenue
₹179.3 Cr
Net income
₹10.9 Cr
See stock holdings
Top mutual fund holders
Motilal Oswal S&P BSE Healthcare ETF
0.00%
Motilal Oswal BSE Healthcare ETF
0.00%
About Medicamen Biotech
Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.
Company address
1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, , 110019

FAQs

How to Buy Medicamen Biotech Ltd Stock?
What is the Share Price of Medicamen Biotech Ltd?
What is the Market Cap of Medicamen Biotech Ltd?
In which sector / industry does Medicamen Biotech Ltd operate?
What was the revenue of Medicamen Biotech Ltd?
What is the PE ratio of Medicamen Biotech Ltd?
What is the 52 week high price of Medicamen Biotech Ltd?
What is the 52 week low price of Medicamen Biotech Ltd?
Can fractional shares of Medicamen Biotech Ltd be purchased?